Joint Annual Collaborators' Meeting 2025 - Agenda
THURSDAY 15 MAY 2025
| 12:00 - 14:00 | Registration and buffet lunch | |
| 14:00 - 14:10 | Introduction and welcome | Rory Collins (CTSU, Oxford) |
| 14:10 - 14:40 | Changing the face of the trials of medical procedures |
Rasha Al-Lamee (Imperial College London) |
| 14:40 - 15:00 | EMPA-KIDNEY health economics | Boby Mihaylova (HERC, Oxford) |
| 15:00 - 15:30 | 30 years of carotid surgery trials in 30 minutes | Richard Bulbulia (CTSU, Oxford), Alison Halliday (Nuffield Department of Surgical Sciences, Oxford) |
| 15:30 - 15:45 | Break | |
| 15:45 - 16:15 | Latest data on trials of GLP-1 receptor agonists in diabetic kidney disease | Peter Rossing (Steno Diabetes Center, Copenhagen) |
| 16:15 - 16:45 | PROTECT-V and dialysis trials | Rona Smith (Cambridge University Hospitals) |
| 16:45 - 17:15 | Early days of CTSU: trials and tribulations | Rory Collins (CTSU, Oxford) |
| 19:00 - 20:00 | Drinks reception | |
| 20:00 | Dinner |
FRIDAY 16 MAY 2025
| 07:00 - 08:45 | Registration and breakfast | |
| 09:00 - 09:05 | Introduction and welcome |
Jane Armitage |
| 09:05 - 09:20 | EMPA-KIDNEY MRI substudy results |
Doreen Zhu |
| 09:20 - 09:35 | EASi-KIDNEY update: vicadrostat for chronic kidney disease | Parminder Judge (CTSU, Oxford) |
| 09:35 - 09:55 | ORION-4 update: inclisiran for secondary prevention of cardiovascular disease | Louise Bowman (CTSU, Oxford) |
| 09:55 - 10:15 | ASCEND-PLUS update: semaglutide for primary prevention of cardiovascular disease | David Preiss (CTSU, Oxford) |
| 10:15 - 10:40 | Break | |
| 10:40 - 11:00 | LENS results: the effect of fenofibrate on diabetic retinopathy | Mohammed Zayed (CTSU, Oxford) |
| 11:00 - 11:30 | UKPDS long-term follow-up results | Amanda Adler (Radcliffe Department of Medicine, Oxford) |
| 11:30 - 12:00 | Levels of evidence in therapy and prevention | Peter Jüni (CTSU, Oxford) |
| 12:00 - 13:00 |
Lunch |